Home
Stock screener
Insider screener
Rankings
Watchlist
Sign in
Create account
Stocks
·
Health care
· Pharmaceutical Preparations
VNDA
Vanda Pharmaceuticals Inc.
VNDA
Clue Score
24
United States
Fiscal year ends December
CIK 0001347178
Results filed 28 Oct 2026
Add to watchlist
Overview
Financials
Insiders
Summary
By person
Transactions
What the insiders did
Net buying
1 month
12 months
120 months
By person
12 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Charles Cliff Duncan
Director
$38.09K
(3)
—
+$38.09K
108,701
0.1798%
$413.52K
—
Mihael Hristos Polymeropoulos
President and CEO
—
—
—
2,704,496
4.47%
$10.29M
+44.5%
Gunther Birznieks
SVP, Business Development
—
—
—
494,197
0.8174%
$1.88M
+57.6%
Kevin Patrick Moran
SVP, CFO & Treasurer
—
—
—
411,380
0.6804%
$1.56M
+79.8%
Timothy Williams
SVP & General Counsel
—
—
—
377,450
0.6243%
$1.44M
+91.8%
Joakim Wijkstrom
SVP, Chief Marketing Officer
—
—
—
333,469
0.5515%
$1.27M
+156.9%
Richard W Dugan
Director
—
—
—
219,054
0.3623%
$833.33K
+85.3%
Phaedra Chrousos
Director
—
—
—
164,950
0.2728%
$627.50K
+157.2%
Anne Sempowski Ward
Director
—
—
—
160,667
0.2657%
$611.21K
+168.5%
Tage Honore
Director
—
—
—
135,069
0.2234%
$513.83K
+110.2%
Stephen Ray Mitchell
Director
—
—
—
112,846
0.1866%
$429.29K
+126.3%
Daniel Patrick McGuire
SVP, GC and Secretary
—
—
—
109,982
0.1819%
$418.39K
+266.8%